Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Legend Biotech’s Carvykti Accepted for Review by China’s CDE
January 26, 2025
Company
Deals
F-star Therapeutics and Sino Biopharmaceutical Face Delays in Proposed Acquisition
January 26, 2025
Company
Drug
CSPC’s ALMB-0168 Receives NMPA Approval for Osteoarthritis Clinical Study
January 26, 2025
Company
Drug
RemeGen’s RC108 Receives FDA Go-Ahead for Phase I Clinical Study
January 26, 2025
Company
Drug
Simcere Receives NMPA Clearance for SIM0348 Clinical Study
January 26, 2025
Company
Deals
Skynor Medical Raises RMB 100 Million in Financing Round for Market Expansion
January 26, 2025
Company
Deals
Sichuan Kelun Completes RMB 1.5 Billion Financing Round for Kelun-Biotech
January 26, 2025
Company
Drug
Everest Medicines’ Nefecon Receives Priority Review Recommendation from CDE
January 26, 2025
Company
Drug
BrightGene Receives NMPA Approval for BGM0504 Clinical Trial
January 26, 2025
Drug
Anhui Anke Biotechnology Receives NMPA Approval for AK2017 Clinical Study
January 26, 2025
Company
Drug
AstraZeneca’s Nexium Approved by NMPA for Adolescent GERD Treatment
January 26, 2025
Company
Deals
Sino Biopharmaceutical Secures Rights to Shionogi’s COVID-19 Therapy Ensitrelvir
January 26, 2025
1
2
…
1,060
1,061
1,062
1,063
1,064
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?